Literature DB >> 19427431

A history of systemic hypertension and incident heart failure hospitalization in patients with acute myocardial infarction and left ventricular systolic dysfunction.

Ali Ahmed1, Bertram Pitt.   

Abstract

The associations of a history of hypertension with subsequent outcomes after acute myocardial infarction have not been examined in propensity-matched studies. Of the 6,632 patients with acute myocardial infarctions and left ventricular systolic dysfunction in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS), 4,407 had histories of hypertension. Propensity scores for a history of hypertension, estimated for each patient using 64 baseline characteristics, were used to match 1,990 pairs of patients with and without hypertension. Matched Cox regression models were used to estimate associations between hypertension and outcomes during a mean of 16 months of follow-up. Heart failure (HF) hospitalization occurred in 11.9% and 8.8% of patients, respectively, with and without hypertension (hazard ratio [HR] for hypertension vs no hypertension 1.36, 95% confidence interval [CI] 1.10 to 1.68, p = 0.004). The association between a history of hypertension and HF hospitalization was significant only in patients without previous HF (n = 3,495, HR 1.48, 95% CI 1.18 to 1.84, p = 0.001), but not in those with previous HF (n = 485, HR 1.09, 95% CI 0.73 to 1.62, p = 0.688, p for interaction = 0.179). A history of hypertension was not associated with all-cause mortality (HR 1.02, 95% CI 0.86 to 1.22, p = 0.790) or cardiovascular hospitalization (HR 1.08, 95% CI 0.92 to 1.27, p = 0.339). In conclusion, a history of hypertension was associated with subsequent HF hospitalization after acute myocardial infarction, especially in patients without histories of HF, suggesting that hypertension increased the risk for hospitalization with incident HF but did not affect hospitalization for worsening HF symptoms in those with prevalent HF.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19427431      PMCID: PMC2924591          DOI: 10.1016/j.amjcard.2009.01.347

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  29 in total

1.  Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores.

Authors:  S T Normand; M B Landrum; E Guadagnoli; J Z Ayanian; T J Ryan; P D Cleary; B J McNeil
Journal:  J Clin Epidemiol       Date:  2001-04       Impact factor: 6.437

Review 2.  Additive improvement of left ventricular remodeling by aldosterone receptor blockade with eplerenone and angiotensin II type 1 receptor antagonist in rats with myocardial infarction.

Authors:  Minoru Yoshiyama; Takashi Omura; Jyunichi Yoshikawa
Journal:  Nihon Yakurigaku Zasshi       Date:  2004-08

3.  Lifetime risk for developing congestive heart failure: the Framingham Heart Study.

Authors:  Donald M Lloyd-Jones; Martin G Larson; Eric P Leip; Alexa Beiser; Ralph B D'Agostino; William B Kannel; Joanne M Murabito; Ramachandran S Vasan; Emelia J Benjamin; Daniel Levy
Journal:  Circulation       Date:  2002-12-10       Impact factor: 29.690

4.  Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study.

Authors:  J S Gottdiener; A M Arnold; G P Aurigemma; J F Polak; R P Tracy; D W Kitzman; J M Gardin; J E Rutledge; R C Boineau
Journal:  J Am Coll Cardiol       Date:  2000-05       Impact factor: 24.094

5.  Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Authors:  Bertram Pitt; Willem Remme; Faiez Zannad; James Neaton; Felipe Martinez; Barbara Roniker; Richard Bittman; Steve Hurley; Jay Kleiman; Marjorie Gatlin
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

6.  Prognosis after initial myocardial infarction: the Framingham study.

Authors:  W B Kannel; P Sorlie; P M McNamara
Journal:  Am J Cardiol       Date:  1979-07       Impact factor: 2.778

7.  Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction.

Authors:  Masaru Hayashi; Takayoshi Tsutamoto; Atsuyuki Wada; Takashi Tsutsui; Chitose Ishii; Keijin Ohno; Masanori Fujii; Atsushi Taniguchi; Tomokazu Hamatani; Yoshitaka Nozato; Ken Kataoka; Naoki Morigami; Masato Ohnishi; Masahiko Kinoshita; Minoru Horie
Journal:  Circulation       Date:  2003-05-05       Impact factor: 29.690

8.  Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy.

Authors:  Robert N Doughty; Gillian A Whalley; Helen A Walsh; Greg D Gamble; José López-Sendón; Norman Sharpe
Journal:  Circulation       Date:  2004-01-05       Impact factor: 29.690

9.  Effect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement trial).

Authors:  Satish Kenchaiah; Marc A Pfeffer; Martin St John Sutton; Ted Plappert; Jean-Lucien Rouleau; Gervasio A Lamas; Zion Sasson; John O Parker; Edward M Geltman; Scott D Solomon
Journal:  Am J Cardiol       Date:  2004-07-01       Impact factor: 2.778

10.  History of hypertension and eplerenone in patients with acute myocardial infarction complicated by heart failure.

Authors:  Bertram Pitt; Ali Ahmed; Thomas E Love; Henry Krum; Jose Nicolau; José S Cardoso; Alexander Parkhomenko; Michael Aschermann; Ramon Corbalán; Henry Solomon; Harry Shi; Faiez Zannad
Journal:  Hypertension       Date:  2008-06-16       Impact factor: 10.190

View more
  6 in total

1.  A propensity-matched study of the association of diabetes mellitus with incident heart failure and mortality among community-dwelling older adults.

Authors:  Brita Roy; Pushkar P Pawar; Ravi V Desai; Gregg C Fonarow; Marjan Mujib; Yan Zhang; Margaret A Feller; Fernando Ovalle; Inmaculada B Aban; Thomas E Love; Ami E Iskandrian; Prakash Deedwania; Ali Ahmed
Journal:  Am J Cardiol       Date:  2011-09-22       Impact factor: 2.778

2.  Impact of baseline systolic blood pressure on long-term outcomes in patients with advanced chronic systolic heart failure (insights from the BEST trial).

Authors:  Ravi V Desai; Maciej Banach; Mustafa I Ahmed; Marjan Mujib; Inmaculada Aban; Thomas E Love; Michel White; Gregg Fonarow; Prakash Deedwania; Wilbert S Aronow; Ali Ahmed
Journal:  Am J Cardiol       Date:  2010-07-15       Impact factor: 2.778

3.  Effect of warfarin on outcomes in septuagenarian patients with atrial fibrillation.

Authors:  Brita Roy; Ravi V Desai; Marjan Mujib; Andrew E Epstein; Yan Zhang; Jason Guichard; Linda G Jones; Margaret A Feller; Mustafa I Ahmed; Inmaculada B Aban; Thomas E Love; Raynald Levesque; Michel White; Wilbert S Aronow; Gregg C Fonarow; Ali Ahmed
Journal:  Am J Cardiol       Date:  2011-11-24       Impact factor: 2.778

4.  The impact of pressure overload on coronary vascular changes following myocardial infarction in rats.

Authors:  Jiqiu Chen; Artiom Petrov; Elisa Yaniz-Galende; Lifan Liang; Hans J de Haas; Jagat Narula; Roger J Hajjar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-28       Impact factor: 4.733

5.  Relation of baseline systolic blood pressure and long-term outcomes in ambulatory patients with chronic mild to moderate heart failure.

Authors:  Maciej Banach; Vikas Bhatia; Margaret A Feller; Marjan Mujib; Ravi V Desai; Mustafa I Ahmed; Jason L Guichard; Inmaculada Aban; Thomas E Love; Wilbert S Aronow; Michel White; Prakash Deedwania; Gregg Fonarow; Ali Ahmed
Journal:  Am J Cardiol       Date:  2011-02-04       Impact factor: 2.778

6.  A propensity-matched study of the comparative effectiveness of angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors in heart failure patients age ≥ 65 years.

Authors:  Yan Zhang; Gregg C Fonarow; Paul W Sanders; Firoozeh Farahmand; Richard M Allman; Inmaculada B Aban; Thomas E Love; Raynald Levesque; Meredith L Kilgore; Ali Ahmed
Journal:  Am J Cardiol       Date:  2011-09-03       Impact factor: 2.778

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.